secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2026-05-19T20:27:34+00:00
Accession:  0001193125-26-230852
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Larimar shareholders approve increase in authorized shares to 215M; reelect three directors
--------------------------------------------------------------------------------

- Shareholders approved amendment increasing authorized common shares from 115M to 215M (89.7M for, 1.05M against).
- Three Class III directors (Frank Thomas, Carole Ben-Maimon, Joseph Truitt) reelected with >66M votes each.
- Advisory vote on executive compensation passed (73.8M for, 1.5M against); one-year frequency selected.
- Ratification of PricewaterhouseCoopers as independent auditor for FY 2026 (90.8M for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000119312526230852/0001193125-26-230852-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000119312526230852/lrmr-20260519.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-230852

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer